...BRCA2) are the genetic events known to date that confer the highest risk of prostate cancer (8.6-fold in men ≤65 years)....
...BRCA2 mutations exhibited a characteristic combination of substitution mutation signatures and a distinctive profile of ...
...BRCA2 function in homologous recombination, we expressed human BRCA2 in control mouse hybridoma cells, as well as those ...
...BRCA2 mutation carriers has not been reported. The KL-VS variant was genotyped in women of European ancestry carrying a ...
...BRCA2 and more recently 19 genes and genetic loci that confer a more moderate risk.The pace of discovery is accelerating...
...BRCA2 has led to the introduction of genetic tests more complex every time for the evaluation of the hereditary cancer r...
...BRCA2-deficient cells, has shown promising clinical efficacy in nonrandomized phase II trials in patients with ovarian c...
...BRCA2 germline mutations, especially if at a young age. Screening paradigms based on molecular and morphological feature...
...BRCA2 as FPC candidate genes. Results The CDKN2A mutation rate in the 225 PC cases was 5.7%. The CDKN2A founder mutatio...
...BRCA2 genes, germline mutations are detected in <20% of families with a presumed genetic predisposition for breast and o...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
